Back

Signatures of mast cell activation are associated with severe COVID-19

Tan, J.; Anderson, D.; Rathore, A. P. S.; O'Neill, A.; Mantri, C. K.; Saron, W. A. A.; Lee, C.; Chu, W. C.; Kang, A.; Foo, R.; Kalimuddin, S.; Low, J.; Ho, L.; Tambyah, P.; Burke, T. W.; Woods, C. W.; Chan, K. R.; Karhausen, J.; St John, A. L.

2021-06-01 infectious diseases
10.1101/2021.05.31.21255594 medRxiv
Show abstract

Lung inflammation is a hallmark of Coronavirus disease 2019 (COVID-19) in severely ill patients and the pathophysiology of disease is thought to be immune-mediated. Mast cells (MCs) are polyfunctional immune cells present in the airways, where they respond to certain viruses and allergens, often promoting inflammation. We observed widespread degranulation of MCs during acute and unresolved airway inflammation in SARS-CoV-2-infected mice and non-human primates. In humans, transcriptional changes in patients requiring oxygen supplementation also implicated cells with a MC phenotype. MC activation in humans was confirmed, through detection of the MC-specific protease, chymase, levels of which were significantly correlated with disease severity. These results support the association of MC activation with severe COVID-19, suggesting potential strategies for intervention.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.